Rating Change
Guggenheim analysts reiterated a Buy rating on Elevance Health Inc. (NYSE:ELV) on July 16, 2026.
reiterateNYSE:ELV
Guggenheim Reiterates Buy Rating on Elevance Health Inc. (ELV)
Rating Change Guggenheim analysts reiterated a Buy rating on Elevance Health Inc. (NYSE:ELV) on July 16, 2026. Market Context Elevance Health Inc.
Market Context
Elevance Health Inc. operates in the Healthcare sector. The stock currently trades at $372.85 with a market capitalization of $80.0B. The stock has gained 18.3% over the past 52 weeks.
Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Elevance Health Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Elevance Health Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 16, 2026 | Wells Fargo | Overweight | N/A |
| Jul 16, 2026 | RBC Capital | Sector Perform | N/A |
| Jul 16, 2026 | Guggenheim | Buy | N/A |
| Jul 16, 2026 | Barclays | Overweight | N/A |
| Jul 16, 2026 | Baird | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View ELV Stock Page
Frequently Asked Questions
What does a Buy rating mean for ELV?
A Buy rating from Guggenheim reflects the analyst's outlook on Elevance Health Inc. (NYSE:ELV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ELV forecast page.
